The data show that up to 80% of people who are diagnosed with pancreatic cancer have either recently developed Type 2 diabetes or have prediabetes.

Glucagon-like peptide 1 (GLP-1) drugs, such as Ozempic, are intended for type 2 diabetes patients and people with obesity, ...

Glucagon-like peptide 1 (GLP-1) drugs, such as Ozempic, are intended for type 2 diabetes patients and people with obesity, ...